RE001 T cell injection

· Henan Cancer Hospital

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RE001 T cell injection, covering 2024-08-09 to 2024-08-09. Get the full timeline:

Most recent: Clinical Trial Update: RE001 T Cell Injection for the Treatment of KRAS G12V Mutated Solid Tumors [Phase 1]